UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A Phenotype-Genotype Approach to Predicting CYP450 and P-Glycoprotein Drug Interactions With the Mixed Inhibitor/Inducer Tipranavir/Ritonavir

Clinical pharmacology and therapeutics, 2010-06, Vol.87 (6), p.735-742

2010

Volltextzugriff (PDF)

P1129 EFFECT OF HCV GENOTYPE-1 SUBTYPE ON RESPONSE TO FALDAPREVIR PLUS PEGYLATED INTERFERON a-2a AND RIBAVIRIN IN TREATMENT-NAIVE PATIENTS: POOLED DATA FROM PHASE III TRIALS

Journal of hepatology, 2014-04, Vol.60 (1), p.S457-S457

2014

Volltextzugriff (PDF)

P723 FALDAPREVIR PLUS PEGYLATED INTERFERON/RIBAVIRIN DID NOT INCREASE ANAEMIA COMPARED WITH PEGYLATED INTERFERON/RIBAVIRIN IN HCV GENOTYPE-1, TREATMENT-NAIVE PATIENTS: POOLED ANALYSIS OF PHASE III STUDIES

Journal of hepatology, 2014-04, Vol.60 (1), p.S310-S311

2014

Volltextzugriff (PDF)

P1118 NO EFFECT OF FALDAPREVIR ON RENAL FUNCTION IN TREATMENT-NAIVE PATIENTS WITH CHRONIC HCV GENOTYPE-1 INFECTION: POOLED DATA FROM TWO PHASE III TRIALS

Journal of hepatology, 2014-04, Vol.60 (1), p.S451-S451

2014

Volltextzugriff (PDF)

P724 VIROLOGICAL RESPONSE IN TREATMENT-NAIVE PATIENTS WITH CHRONIC HCV GENOTYPE-1 INFECTION RECEIVING FALDAPREVIR PLUS PEGYLATED INTERFERON a-2a AND RIBAVIRIN IS UNAFFECTED BY RIBAVIRIN DOSE REDUCTION

Journal of hepatology, 2014-04, Vol.60 (1), p.S311-S311

2014

Volltextzugriff (PDF)

VERxVE 144 week results: nevirapine extended‐release (NVP XR) QD versus NVP immediate‐release (IR) BID with FTC/TDF in treatment‐naïve HIV‐1 patients

Journal of the International AIDS Society, 2012-11, Vol.15 (S4), p.1-1

2012

Volltextzugriff (PDF)

TRANxITION 144‐week results: switching virologically stable HIV patients from immediate‐release nevirapine (NVP IR) to extended‐release NVP (XR)

Journal of the International AIDS Society, 2012-11, Vol.15 (S4), p.1-1

2012

Volltextzugriff (PDF)

A Phenotype-Genotype Approach to Predicting CYP450 and P-Glycoprotein Drug Interactions With the Mixed Inhibitor/ InducerTipranavir/Ritonavir

Clinical pharmacology and therapeutics, 2010, Vol.87 (6), p.735-742

2010

Volltextzugriff (PDF)

Vaccination of Seropositive Subjects with CHIRON CMV gB Subunit Vaccine Combined with MF59 Adjuvant for Production of CMV Immune Globulin

Viral immunology, 2000, Vol.13 (1), p.49-56

2000

Volltextzugriff (PDF)

Verxve 144-Week Results: Nevirapine Extended Release (NVP XR) Qd Versus NVP Immediate Release (IR) Bid with FTC/TDF in Treatment-Naive HIV-1 Patients

Journal of AIDS & clinical research, 2013, Vol.4 (8)

2013

Volltextzugriff (PDF)

Comparative in vitro activity of ceftizoxime, cefoperazone, and cefoxitin against anaerobic bacteria

Antimicrobial Agents and Chemotherapy, 1981-11, Vol.20 (5), p.683-685

1981

Volltextzugriff (PDF)

Thalidomide in Low Intermittent Doses Does Not Prevent Recurrence of Human Immunodeficiency Virus—Associated Aphthous Ulcers

The Journal of infectious diseases, 2001-01, Vol.183 (2), p.343-346

2001

Volltextzugriff (PDF)

Comparison of visuwell enzyme immunoassay to culture for detection of group A streptococcus in throat swab specimens

Diagnostic microbiology and infectious disease, 1988-12, Vol.11 (4), p.181-187

1988

Volltextzugriff (PDF)

The effectiveness of six disinfectants in inactivation of reovirus 3

Microbios, 1984, Vol.41 (163), p.31

1984

Volltextzugriff (PDF)

A Pilot Survey of Endemic and Imported Parasitic Infections in Manitoba

Canadian journal of public health, 1978-11, Vol.69 (6), p.475-480

1978

Volltextzugriff (PDF)

The relative effectiveness of commonly used disinfectants in inactivation of echovirus 11

The Journal of hygiene, 1978-08, Vol.81 (1), p.77-87

1978

Volltextzugriff (PDF)

The relative resistance of f2 bacteriophage to inactivation by disinfectants

The Journal of hygiene, 1979-08, Vol.83 (1), p.111-119

1979

Volltextzugriff (PDF)

The relative effectiveness of commonly used disinfectants in inactivation of coxsackievirus B5

The Journal of hygiene, 1978-12, Vol.81 (3), p.389-397

1978

Volltextzugriff (PDF)

Wescodyne: lack of activity against poliovirus in the presence of organic matter

Health laboratory science, 1978-07, Vol.15 (3), p.133

1978

Volltextzugriff (PDF)

Evaluation of the modified Visuwell Strep-A enzyme immunoassay for detection of group-A Streptococcus from throat swabs

Diagnostic microbiology and infectious disease, 1991-07, Vol.14 (4), p.281-285

1991

Volltextzugriff (PDF)

Anti-immunoglobulin analysis by diffusion patterns of inhibition and facilitation of complementary lysis in agar. II. Diffusion-lysis as a method for recognizing in vivo immunosuppressive activity of anti-immunoglobulins

Journal of immunological methods, 1975-02, Vol.6 (4), p.375-384

1975

Volltextzugriff (PDF)

Su1056 Effect of HCV Genotype-1 Subtype on Response to Faldaprevir Plus Pegylated Interferon α-2A and Ribavirin in Treatment-Naïve Patients: Pooled Data From Phase III Trials

Gastroenterology (New York, N.Y. 1943), 2014-05, Vol.146 (5), p.S-976-S-976

2014

Volltextzugriff (PDF)

Su1053 Virological Response in Treatment-Naïve Patients With Chronic HCV Genotype-1 Infection Receiving Faldaprevir Plus Pegylated Interferon α-2A and Ribavirin Is Unaffected by Ribavirin Dose Reduction

Gastroenterology (New York, N.Y. 1943), 2014-05, Vol.146 (5), p.S-975-S-976

2014

Volltextzugriff (PDF)

Su1060 Faldaprevir Plus Pegylated Interferon/Ribavirin Did Not Increase Anaemia Compared With Pegylated Interferon/Ribavirin in HCV Genotype-1, Treatment-Naïve Patients: Pooled Analysis of Phase III Studies

Gastroenterology (New York, N.Y. 1943), 2014-05, Vol.146 (5), p.S-977-S-977

2014

Volltextzugriff (PDF)

Les Tchèques à la tête de l’Europe La présidence tchèque de l’Union européenne en 2009

Revue d'études comparatives est-ouest, 2009-03, Vol.N° 40 (1), p.19-43

Drulák, Petr

2009

Volltextzugriff (PDF)

1 – 25 von 28

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(22)
Mit Volltextzugriff
(20)

Publikationsform

Artikel
(27)
magazinearticle
(1)

Sprache

Englisch
(25)
Französisch
(3)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(10)
Science & Technology
(10)
Gastroenterology And Hepatology
(7)
Humans
(7)
Biological And Medical Sciences
(5)
Disinfectants - Pharmacology
(5)
Adult
(4)
Hiv
(4)
Microbiology
(4)
Aids
(3)
Antiseptics
(3)
Child
(3)
Ethanol
(3)
Fundamental And Applied Biological Sciences. Psychology
(3)
Human Enterovirus B
(3)
Human Immunodeficiency Virus
(3)
Hydroxides
(3)
Infectious Diseases
(3)
Public, Environmental & Occupational Health
(3)
Sodium
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A Phenotype-Genotype Approach to Predicting CYP450 and P-Glycoprotein Drug Interactions With the Mixed Inhibitor/Inducer Tipranavir/Ritonavir

P1129 EFFECT OF HCV GENOTYPE-1 SUBTYPE ON RESPONSE TO FALDAPREVIR PLUS PEGYLATED INTERFERON a-2a AND RIBAVIRIN IN TREATMENT-NAIVE PATIENTS: POOLED DATA FROM PHASE III TRIALS

P723 FALDAPREVIR PLUS PEGYLATED INTERFERON/RIBAVIRIN DID NOT INCREASE ANAEMIA COMPARED WITH PEGYLATED INTERFERON/RIBAVIRIN IN HCV GENOTYPE-1, TREATMENT-NAIVE PATIENTS: POOLED ANALYSIS OF PHASE III STUDIES

P1118 NO EFFECT OF FALDAPREVIR ON RENAL FUNCTION IN TREATMENT-NAIVE PATIENTS WITH CHRONIC HCV GENOTYPE-1 INFECTION: POOLED DATA FROM TWO PHASE III TRIALS

P724 VIROLOGICAL RESPONSE IN TREATMENT-NAIVE PATIENTS WITH CHRONIC HCV GENOTYPE-1 INFECTION RECEIVING FALDAPREVIR PLUS PEGYLATED INTERFERON a-2a AND RIBAVIRIN IS UNAFFECTED BY RIBAVIRIN DOSE REDUCTION

VERxVE 144 week results: nevirapine extended‐release (NVP XR) QD versus NVP immediate‐release (IR) BID with FTC/TDF in treatment‐naïve HIV‐1 patients

TRANxITION 144‐week results: switching virologically stable HIV patients from immediate‐release nevirapine (NVP IR) to extended‐release NVP (XR)

A Phenotype-Genotype Approach to Predicting CYP450 and P-Glycoprotein Drug Interactions With the Mixed Inhibitor/ InducerTipranavir/Ritonavir

Vaccination of Seropositive Subjects with CHIRON CMV gB Subunit Vaccine Combined with MF59 Adjuvant for Production of CMV Immune Globulin

Verxve 144-Week Results: Nevirapine Extended Release (NVP XR) Qd Versus NVP Immediate Release (IR) Bid with FTC/TDF in Treatment-Naive HIV-1 Patients

Comparative in vitro activity of ceftizoxime, cefoperazone, and cefoxitin against anaerobic bacteria

Thalidomide in Low Intermittent Doses Does Not Prevent Recurrence of Human Immunodeficiency Virus—Associated Aphthous Ulcers

Comparison of visuwell enzyme immunoassay to culture for detection of group A streptococcus in throat swab specimens

The effectiveness of six disinfectants in inactivation of reovirus 3

A Pilot Survey of Endemic and Imported Parasitic Infections in Manitoba

The relative effectiveness of commonly used disinfectants in inactivation of echovirus 11

The relative resistance of f2 bacteriophage to inactivation by disinfectants

The relative effectiveness of commonly used disinfectants in inactivation of coxsackievirus B5

Wescodyne: lack of activity against poliovirus in the presence of organic matter

Evaluation of the modified Visuwell Strep-A enzyme immunoassay for detection of group-A Streptococcus from throat swabs

Anti-immunoglobulin analysis by diffusion patterns of inhibition and facilitation of complementary lysis in agar. II. Diffusion-lysis as a method for recognizing in vivo immunosuppressive activity of anti-immunoglobulins

Su1056 Effect of HCV Genotype-1 Subtype on Response to Faldaprevir Plus Pegylated Interferon α-2A and Ribavirin in Treatment-Naïve Patients: Pooled Data From Phase III Trials

Su1053 Virological Response in Treatment-Naïve Patients With Chronic HCV Genotype-1 Infection Receiving Faldaprevir Plus Pegylated Interferon α-2A and Ribavirin Is Unaffected by Ribavirin Dose Reduction

Su1060 Faldaprevir Plus Pegylated Interferon/Ribavirin Did Not Increase Anaemia Compared With Pegylated Interferon/Ribavirin in HCV Genotype-1, Treatment-Naïve Patients: Pooled Analysis of Phase III Studies

Les Tchèques à la tête de l’Europe La présidence tchèque de l’Union européenne en 2009

Suchergebnisse filtern